24Jun 2018

A COMPARATIVE STUDY ON EVALUATION OF SERUM LDH IN MANAGEMENT OF HEAD AND NECK SQUAMOUS CELL CARCINOMA.

  • Professor, Dept of ENT, Madurai Medical College. Madurai.
  • Professor and HOD, Dept of ENT, Madurai Medical College. Madurai.
  • Dept of ENT, Madurai Medical College. Madurai.
Crossref Cited-by Linking logo

  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

A neoplasm or carcinoma is an abnormal mass of tissue, the growth of which exceeds and is uncoordinated with that of normal tissues and persists in the same excessive manner after cessation of stimuli which evoked the change1. Persistence of cancerous cells, even after the stimuli is removed is due to the heritable genetic change that is passed to tumor cell progeny. The genetic change leads to excess unregulated proliferation, which is also autonomous. All tumor cells have two compartments 1. Proliferating neoplastic cells which is the parenchyma 2. Supportive stroma which is connective tissue and blood vessels. Head and neck malignancy poses a significant health problem in INDIA. In INDIA population registries estimates annual incidence of 25000 new cases of carcinoma larynx alone . Head and neck malignancies have numerous hidden areas called? coffin corners? where tumor continues to grow. Eventhough premalignant lesions can be clearly identified there is a significant rate of late presentation in our country. D] Early detection and treatment is the only chance for better outcome as these tumors are aggressive compared to tumors elsewhere. The importance of early detection will help both in cure and lessening the morbidity, thereby enabling the patients to lead a qualitatively better life. The need for an easy and simple test that is suggestive of cancer quite early even before the patients become symptomatic and which can be done during routine visits to the health care facility at an affordable cost.

  1. Willis ra : the spread of tumors in human body.london.
  2. Singh b. Molecular pathogenesis of head and neck cancer.journal of surgical oncology 2008 ; 97:634-9
  3. Gasco m,crook t.the p53 network in head and neck cancer.oral oncology 2003;39:222-31
  4. Ho t, wei,sturgis em. Epidemiology of carcinogen metabolism genes and risk of squamous cell carcinoma of the head and neck.head and neck 2007;29:682-99
  5. du w,searle js.the rb pathway and cancer therapeutics.current drug targets 2009;10:581-9.
  6. Foulkes wd,brunet js,sieh w et al .familial risks of squamous cell carcinoma of the head and neck:retrospective case-control study.british medical journal 1996;313:716-21.
  7. Kalyankrishna s ,grandis jr.epidermal growth factor receptor biology in head and neck cancer.journal of clinical oncology 2006;24:2666-72.
  8. Storey a,thomas m, kalita a et al .role of a p53 polymorphism in the development of human papilloma virus ?associated cancer.nature 1998;393:229-34.
  9. Mork j, moller b,glattre e. Familial risk in head abnd neck squamous cell carcinoma diagnosed before the age of 45:a population based study.oral oncology 1999;35:360-7.
  10. Quon h,liu ff,cummings bj.potential molecular prognostic markers in head and neck squamous cell carcinomas.head and neck 2001;23:147-59.
  11. national minimum and advisory head and neck cancer data sets.british association of head and neck oncologists,1999.
  12. Thawley s.e.and o?leary m.o {1992} malignant neoplasms of the oropharynx,in otolaryngology-head? and neck surgery (c.w,cummings,j.fredrickson, l.a harker,c.j krause and d.e.schuller,eds),mobsy,st louis,mo,chap.74,p.1313.
  13. Shah j.p(1996) oral cavity and oropharynx,in head and neck surgery,2 nd edn,mosby-wolfe,london,chap.6,pp167-234
  14. Jakobsson p.a.,eneroth c.m.,killiander d.,moberger g.and martensson b.(1973) historical classification and grading of malignancy in carcinoma of the larynx,acta radiol ther phys biol 12;1-8
  15. stell and maran head and neck surgery,4 th edition
  16. elias m.m.,hilgers f.j.,keus r.b., gregor r;t.,hart a.and balm a.j.(1995) carcinoma of the pyriform sinus; a retrospective analysis of treatment results over a 20year period,clin otolaryngol appl sci20:249-53
  17. hoe c.n.,lamb k.h.,ng w.f and wei w.i.(1996) pathological basis for hypopharyngeal cancer,in proceedings of the ivth international conference on head and neck cancer,the society of head and neck surgeons,alrington,va and the american society of head and neck surgery,pittsburgh,pa,pp.149-55
  18. yu mc,huang tb,henderson be :diet and nasopharyngeal carcinoma: a case- control study in guangzhou,china.int j cancer 43:1077-1082,1989.
  19. pinkerton ke ,et al: interaction of tobacco smoking ,with occupational and environmental factors. In harber ph,et al (eds):occupational and environmental respiratory disease.st.louis,mosby ,1996,pp827-835.
  20. mak-kregar s ,hilgers fjm,levendag pc ,manni jj, lubsen h ,roodenburg jl et al.a nationwide study of the epidiomology,treatment and survival of oropharyngeal carcinoma in the netherlands.european archieves of oto ?rhino-laryngology.1995;252:133-8.

[Arul Sundaresh Kumar Lakshmanaperumal1, N Dhinakaran and Manimala. (2018); A COMPARATIVE STUDY ON EVALUATION OF SERUM LDH IN MANAGEMENT OF HEAD AND NECK SQUAMOUS CELL CARCINOMA. Int. J. of Adv. Res. 6 (Jun). 909-916] (ISSN 2320-5407). www.journalijar.com

Prof Dr N Dhinakaran MS ENT
Professor of ENT

DOI:

Article DOI: 10.21474/IJAR01/7292      
DOI URL: https://dx.doi.org/10.21474/IJAR01/7292

Download Full Paper

Download PDF No. of Downloads: 12 | No. of Views: 70